Development Toward an IN Vivo Model for Cf Gene Therapy - Moira Aitken

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Heart, Lung, and Blood Institute (NHLBI)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 1R29HL050052-01A3
Application #: 2226157
Study Section: Lung Biology and Pathology Study Section (LBPA)

Project Start: 1996-02-01
Project End: 2000-01-31
Budget Start: 1996-02-01
Budget End: 1997-01-31
Support Year: 1
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: University of Washington
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 135646524

City: Seattle
State: WA
Country: United States
Zip Code: 98195

Related projects


NIH 1999 R29 HL	Development Toward an IN Vivo Model for Cf Gene Therapy Aitken, Moira L. / University of Washington
NIH 1998 R29 HL	Development Toward an IN Vivo Model for Cf Gene Therapy Aitken, Moira L. / University of Washington
NIH 1997 R29 HL	Development Toward an IN Vivo Model for Cf Gene Therapy Aitken, Moira L. / University of Washington
NIH 1996 R29 HL	Development Toward an IN Vivo Model for Cf Gene Therapy Aitken, Moira L. / University of Washington

Publications

Halbert, C L; Standaert, T A; Aitken, M L et al. (1997) Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 71:5932-41

Comments

Be the first to comment on Moira Aitken's grant